Showing results (11-20 of 68) with videos related to
Sort By:
Pageof 7
Liver International : Official Journal of the International Association for the Study of the Liver|January 8, 2026
Risk of Extrahepatic Cancer for Metabolic Dysfunction-Associated Steatohepatitis (MASH) in the United States Medicare PopulationYestle Kim, Dominic Nunag, Matthew Davis, et al.Expert Review of Clinical Pharmacology|May 3, 2017
Tenofovir alafenamide for the treatment of chronic hepatitis B virus infectionSyed Abdul Basit, Altaf Dawood, John Ryan, et al.The Lancet. Infectious Diseases|February 14, 2012
Selection of chronic hepatitis B therapy with high barrier to resistanceRobert Gish, Ji-Dong Jia, Stephen Locarnini, et al.Gastroenterology & Hepatology|December 31, 2016
Evolving New Strategies for the Medical Management of Chronic Hepatitis B Virus InfectionTimothy M Block, Tianlun Zhou, Nikhil Anbarasan, et al.Journal of Clinical Gastroenterology|June 11, 2010
A clinical assessment of Wilson disease in patients with concurrent liver diseaseRobert J Wong, Robert Gish, Michael Schilsky, et al.The Journal of Medical Practice Management : MPM|June 12, 2015
A case study of quality improvement methods for complex adaptive systems applied to an academic hepatology programJohn Fontanesi, Anthony Martinez, Toritsesan O Boyo, et al.Gastroenterology Research|January 13, 2025
Evaluating the Impact of Phosphatidylethanol Testing on Hospital OutcomesRakahn Haddadin, Steven Molina, George Trad, et al.Journal of Comparative Effectiveness Research|November 22, 2024
Costs associated with nonalcoholic steatohepatitis disease progression in Medicare patients: a retrospective cohort studyYestle Kim, Joseph Medicis, Matthew Davis, et al.Expert Review of Anti-Infective Therapy|December 15, 2015
Defining the possibilities: is short duration treatment of chronic hepatitis C genotype 1 with sofosbuvir-containing regimens likely to be as effective as current regimens?Shirin Nafisi, Sabyasachi Roy, Robert Gish, et al.Current Medical Research and Opinion|January 9, 2026
Improving cardiovascular risk prediction in metabolic liver disease with a novel biomarker-enhanced modelLars Hegstrom, Yestle Kim, Pete Vu, et al.Pageof 7